Jun 30, 2022 / 12:30PM GMT
Operator
Good morning. My name is Liz, and I will be your conference facilitator. I'd like to welcome everyone to Cara Therapeutics call to discuss the top line results of the KOMFORT Phase II proof-of-concept study in NP. (Operator Instructions)
Please be advised that this call is being recorded. I would now like to introduce Iris Francesconi, Chief Strategy Officer and Head of Investor Relations from Cara Therapeutics. Ms. Francesconi, you may begin the call.
Iris Francesconi - Cara Therapeutics, Inc. - Chief of Corporate Strategy & IR
Thank you, Liz, and good morning, everyone. Earlier today, we issued a press release detailing our top line results for the proof-of-concept study, KOMFORT, in notalgia paresthetica. The press release can be found on our website at www.caratherapeutics.com. You may also listen to a live webcast and replay of today's call on the Investors section of the website. Participating in today's call are Chris Posner, Cara's President and Chief Executive Officer;
Cara Therapeutics Inc to Discuss KOMFORT Phase 2 Topline Data - Conference Call Transcript
Jun 30, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers